Crohn’s Disease Treatment Update: Psoriasis Drug Approved By FDA To Treat Crohn’s Disease

Keytruda Ready to Help More People
October 5, 2016
Liver transplant strengthens bond between firefighter cousins
October 6, 2016
Show all

Crohn’s Disease Treatment Update: Psoriasis Drug Approved By FDA To Treat Crohn’s Disease

The psoriasis medication Stelara has been approved by the FDA to also treat Crohn’s disease.

Johnson & Johnson said on Monday that the U.S. Food and Drug Administration approved the company’s blockbuster psoriasis drug, Stelara, for use in adults with Crohn’s disease.

The drug is approved in the United States to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.

Crohn’s is a chronic inflammatory condition in the gastrointestinal tract, causing abdominal pain, diarrhea, rectal bleeding, weight loss and fever. It affects about 700,000 Americans and nearly 250,000 Europeans, according to the company.

Read Full Article: Crohn’s Disease Treatment Update: Psoriasis Drug Approved By FDA To Treat Crohn’s Disease

Read Full Article: Crohn’s Disease Treatment Update: Psoriasis Drug Approved By FDA To Treat Crohn’s Disease

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.